01 2Astellas Pharma Canada Inc.
02 6Torys LLP
01 22305802
02 22464068
03 22503570
04 22740342
01 8Mirabegron
01 8Extended Release Tablet
01 22018-10-15
02 22022-10-29
03 22023-11-04
04 22029-09-28
Patent Expiration Date : 2022-10-29
Date Granted : 2007-10-16
Brand Name : MYRBETRIQ
Patent Number : 2464068
Filing Date : 2002-10-29
Strength per Unit : 50 mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2022-10-29
Date Granted : 2007-10-16
Patent Expiration Date : 2023-11-04
Date Granted : 2011-04-19
Brand Name : MYRBETRIQ
Patent Number : 2503570
Filing Date : 2003-11-04
Strength per Unit : 50 mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-11-04
Date Granted : 2011-04-19
Patent Expiration Date : 2018-10-15
Date Granted : 2008-11-18
Brand Name : MYRBETRIQ
Patent Number : 2305802
Filing Date : 1998-10-15
Strength per Unit : 50 mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-10-15
Date Granted : 2008-11-18
Patent Expiration Date : 2029-09-28
Date Granted : 2016-05-03
Brand Name : MYRBETRIQ
Patent Number : 2740342
Filing Date : 2009-09-28
Strength per Unit : 50 mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2029-09-28
Date Granted : 2016-05-03
Patent Expiration Date : 2023-11-04
Date Granted : 2011-04-19
Brand Name : MYRBETRIQ
Patent Number : 2503570
Filing Date : 2003-11-04
Strength per Unit : 25 mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-11-04
Date Granted : 2011-04-19
Patent Expiration Date : 2022-10-29
Date Granted : 2007-10-16
Brand Name : MYRBETRIQ
Patent Number : 2464068
Filing Date : 2002-10-29
Strength per Unit : 25 mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2022-10-29
Date Granted : 2007-10-16
Patent Expiration Date : 2018-10-15
Date Granted : 2008-11-18
Brand Name : MYRBETRIQ
Patent Number : 2305802
Filing Date : 1998-10-15
Strength per Unit : 25 mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-10-15
Date Granted : 2008-11-18
Patent Expiration Date : 2029-09-28
Date Granted : 2016-05-03
Brand Name : MYRBETRIQ
Patent Number : 2740342
Filing Date : 2009-09-28
Strength per Unit : 25 mg
Dosage Form : Extended Release Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2029-09-28
Date Granted : 2016-05-03
